Halma (LON:HLMA) Stock Passes Above 200 Day Moving Average – Here’s What Happened

Halma plc (LON:HLMA)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 3,639 and traded as high as GBX 4,098. Halma shares last traded at GBX 4,083, with a volume of 871,438 shares trading hands.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft lifted their price target on Halma from GBX 3,800 to GBX 3,980 and gave the stock a “hold” rating in a research note on Friday, January 16th. Four investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, Halma presently has an average rating of “Moderate Buy” and a consensus target price of GBX 3,737.50.

Halma Stock Up 0.4%

The stock has a 50-day moving average of GBX 3,836.07 and a two-hundred day moving average of GBX 3,639. The company has a market cap of £15.48 billion, a P/E ratio of 44.81, a P/E/G ratio of 2.93 and a beta of 0.92. The company has a debt-to-equity ratio of 43.44, a quick ratio of 1.51 and a current ratio of 2.18.

Halma (LON:HLMA) last released its earnings results on Friday, January 16th. The company reported GBX 55.32 earnings per share for the quarter. Halma had a return on equity of 13.73% and a net margin of 14.63%. On average, research analysts anticipate that Halma plc will post 90.5626134 EPS for the current fiscal year.

Halma Company Profile

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.